Catelani Michael — SEC insider filings
SEC reporting owner CIK 1689394. 22 insider filings on record with FilingPulse; latest filed 2026-09-30.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2020-11-03 to 2026-09-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 6 filings — 34,548 shares, $91,589 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: purchase of 5,500 shares @ $3.64 ($20,020) in Anixa Biosciences Inc, filed 2023-07-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | President, COO, & CFO | 22 | 6 legs · 34,548 sh · $91,589 | — | 17 |
Insider filings — Catelani Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-30 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,500 @ $2.84 | EDGAR |
| 2026-01-06 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2025-01-15 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 9,289 @ $2.15 | EDGAR |
| 2025-01-03 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 6,250 @ $2.40 | EDGAR |
| 2024-05-02 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 1,189 @ $2.52 | EDGAR |
| 2024-01-16 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2023-11-02 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 1,117 @ $2.69 | EDGAR |
| 2023-07-21 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,500 @ $3.64 | EDGAR |
| 2023-05-01 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 865 @ $3.47 | EDGAR |
| 2023-01-04 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2022-11-01 | 4 | Anixa Biosciences Inc (ANIX) | Other (J): 1,069 @ $2.81 | EDGAR |
| 2022-05-02 | 4 | Anixa Biosciences Inc (ANIX) | Other (J): 1,086 @ $2.76 | EDGAR |
| 2022-04-22 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,500 @ $2.66 | EDGAR |
| 2022-04-21 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,509 @ $2.53 | EDGAR |
| 2022-04-15 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2021-11-02 | 4 | Anixa Biosciences Inc (ANIX) | Other (J): 743 @ $4.04 | EDGAR |
| 2021-06-02 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | Anixa Biosciences Inc (ANIX) | Other (J): 1,634 @ $1.84 | EDGAR |
| 2020-12-28 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2020-11-03 | 4 | Anixa Biosciences Inc (ANIX) | Other (J): 1,918 @ $1.56 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1689394 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs